skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Transforming growth factor-{beta}1 regulates fibronectin isoform expression and splicing factor SRp40 expression during ATDC5 chondrogenic maturation

Journal Article · · Experimental Cell Research
 [1];  [1];  [1];  [1];  [1];  [1];  [2];  [3];  [3];  [4];  [3];  [5]
  1. Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA 19107 (United States)
  2. Division of Rheumatology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107 (United States)
  3. Department of Biochemistry and Molecular Pharmacology, Thomas Jefferson University, Philadelphia, PA 19107 (United States)
  4. Cartilage Biology and Orthopaedics Branch, NIAMS, NIH, Bethesda, MD 20892-8022 (United States)
  5. Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA 19107 (United States) and Department of Biochemistry and Molecular Pharmacology, Thomas Jefferson University, Philadelphia, PA 19107 (United States)

Fibronectin (FN) isoform expression is altered during chondrocyte commitment and maturation, with cartilage favoring expression of FN isoforms that includes the type II repeat extra domain B (EDB) but excludes extra domain A (EDA). We and others have hypothesized that the regulated splicing of FN mRNAs is necessary for the progression of chondrogenesis. To test this, we treated the pre-chondrogenic cell line ATDC5 with transforming growth factor-{beta}1, which has been shown to modulate expression of the EDA and EDB exons, as well as the late markers of chondrocyte maturation; it also slightly accelerates the early acquisition of a sulfated proteoglycan matrix without affecting cell proliferation. When chondrocytes are treated with TGF-{beta}1, the EDA exon is preferentially excluded at all times whereas the EDB exon is relatively depleted at early times. This regulated alternative splicing of FN correlates with the regulation of alternative splicing of SRp40, a splicing factor facilitating inclusion of the EDA exon. To determine if overexpression of the SRp40 isoforms altered FN and FN EDA organization, cDNAs encoding these isoforms were overexpressed in ATDC5 cells. Overexpression of the long-form of SRp40 yielded an FN organization similar to TGF-{beta}1 treatment; whereas overexpression of the short form of SRp40 (which facilitates EDA inclusion) increased formation of long-thick FN fibrils. Therefore, we conclude that the effects of TGF-{beta}1 on FN splicing during chondrogenesis may be largely dependent on its effect on SRp40 isoform expression.

OSTI ID:
20972143
Journal Information:
Experimental Cell Research, Vol. 313, Issue 8; Other Information: DOI: 10.1016/j.yexcr.2007.01.028; PII: S0014-4827(07)00043-2; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0014-4827
Country of Publication:
United States
Language:
English

Similar Records

Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathway
Journal Article · Fri Oct 01 00:00:00 EDT 2010 · Experimental Cell Research · OSTI ID:20972143

TrxR2 deficiencies promote chondrogenic differentiation and induce apoptosis of chondrocytes through mitochondrial reactive oxygen species
Journal Article · Sun May 15 00:00:00 EDT 2016 · Experimental Cell Research · OSTI ID:20972143

Overexpression of TGF-β1 enhances chondrogenic differentiation and proliferation of human synovium-derived stem cells
Journal Article · Fri Aug 08 00:00:00 EDT 2014 · Biochemical and Biophysical Research Communications · OSTI ID:20972143